Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Number of holders
-
352
-
Total 13F shares, excl. options
-
26,775,885
-
Shares change
-
+2,459,690
-
Total reported value, excl. options
-
$3,634,288,900
-
Value change
-
+$251,858,628
-
Put/Call ratio
-
193%
-
Number of buys
-
198
-
Number of sells
-
170
-
Price
-
$135.70
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2018
As of 31 Dec 2018 LIGAND PHARMACEUTICALS INC - Common Stock (LGND) had 473 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,775,885 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, MILLENNIUM MANAGEMENT LLC, CARDINAL CAPITAL MANAGEMENT LLC /CT, and Conestoga Capital Advisors, LLC.
This table shows 473 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.